Yeongjin Pharm Reports 3Q Operating Loss of 500 Million KRW... Turned to Deficit Year-on-Year

[Asia Economy Reporter Minwoo Lee] Youngjin Pharmaceutical announced on the 4th that it posted provisional results for the third quarter of this year with sales of 50 billion KRW and an operating loss of 500 million KRW. Compared to the same period last year, sales decreased by 9.3%, and operating profit turned to a loss. Net profit also turned to a loss during the same period, recording a net loss of 300 million KRW.

This content was produced with the assistance of AI translation services.